Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Recruiting
N/A
Interventional Study
Early Gastric Cancer
Advanced Gastric Cancer
Early Lung Cancer
Advanced Lung Cancer
Early Breast Cancer
Advanced Breast Cancer
Early Colon Cancer
Advanced Colon Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 414 (estimated)
- Sponsor
- Ulsan University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 19 years or older
* Diagnosed with early or advanced gastric, lung, breast, or colon cancer
* Starting first-cycle chemotherapy with a new anticancer agent
* Able to use a smartphone without difficulty
* Willing to provide informed consent to participate in the stu…
Contacts